Anavex Life Sciences Corp. (AVXL) vs Nyxoah S.A. (NYXH)

A side-by-side comparison of Anavex Life Sciences Corp. and Nyxoah S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVXL vs NYXH

growth of $100 · dividends reinvested · last 5y
AVXL -86.6% (-33.1%/yr)NYXH -94.1% (-43.3%/yr)AVXL compounded faster over this window
050100150200Start $10020222023202420252026$13$6
AVXL NYXH

AVXL vs NYXH: by the numbers

  • •AVXL is the larger company ($146M vs $142M market cap).
  • •Both run net losses; AVXL's is the smaller (0.00% vs -435.70% net margin).

Metrics side by side

Valuation

MetricAVXLNYXH
P/S ratioN/A5.42
P/B ratio1.301.50

Profitability

MetricAVXLNYXH
Gross margin0.00%63.13%
Operating margin0.00%-827.76%
Net margin0.00%-435.70%
ROE-21.38%-120.33%
ROIC-27.25%-61.13%

Growth (annualized)

MetricAVXLNYXH
Revenue CAGR (5Y)N/A120.68%
Total return CAGR (5Y)-37.74%-45.84%

Frequently asked

How have AVXL and NYXH total returns compared?
Over the past 5 years, AVXL delivered -37.74% and NYXH delivered -45.84% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.